Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 05, 2024
Coronado Research is a consultancy-led, professional services organization operating in the clinical development arena.
read more
Thursday, December 03, 2020
Samsung Bioepis and Biogen announced the FDA has accepted for review the BLA for SB11, a proposed biosimilar referencing Lucentis.
read more
10x Genomics announced expansion plans to support the company’s continued growth in Pleasanton across two properties.
read more
Wednesday, April 25, 2018
ADC Biotechnology has secured £1.14 million in funding from investment managers, Downing.
read more
Friday, February 26, 2021
PharmaLex Group has completed the acquisition of ERA Consulting (ERA).
read more
Wednesday, April 17, 2013
Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from a phase 2 study of ALKS 5461, its novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for ...
read more
AMRI has announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology Consortium (CBC) Center for the Experimental Therapeutics (NExT) Program, centered at the Frederick National Laboratory for Cancer ...
read more
J. David Enloe, Jr., CEO of Ajinomoto Althea was awarded Most Admired CEO in 2017 by the San Diego Business Journal.
read more
Tuesday, February 16, 2021
Ubiquigent has entered into a license agreement with Medivir for Medivir’s preclinical USP7 research program.
read more
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in the U.S., China and throughout the ...
read more
Thursday, December 10, 2020
Lonza has announced an investment to expand its particle engineering and drug product capabilities at its Oregon site.
read more
Wednesday, September 11, 2024
VS-041, a novel and potentially life-saving treatment for heart failure, developed by Vasa Therapeutics, a San Diego-based biotechnology company, has reached a major clinical milestone with the first human subjects dosed at Quotient Sciences’ ...
read more
The Ritedose Corporation, a pharmaceutical manufacturer specializing in Blow-Fill-Seal (BFS) technology, unveiled its new distribution and logistics facility at Performance Park during a ribbon-cutting ceremony. The grand opening event included ...
read more
Charles River Laboratories announced the planned opening of the Charles River Accelerator and Development Lab (CRADL™) in South San Francisco in early 2020.
read more
Abzena has announced a $10M investment of growth capital from Biospring Partners, a New York based investment firm.
read more